Ricky Hsu

455 total citations
20 papers, 255 citations indexed

About

Ricky Hsu is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Ricky Hsu has authored 20 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Emergency Medicine and 8 papers in Virology. Recurrent topics in Ricky Hsu's work include HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (10 papers) and HIV/AIDS Research and Interventions (9 papers). Ricky Hsu is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (10 papers) and HIV/AIDS Research and Interventions (9 papers). Ricky Hsu collaborates with scholars based in United States and United Kingdom. Ricky Hsu's co-authors include Jennifer S Fusco, Vani Vannappagari, Laurence Brunet, Gregory Fusco, Karam Mounzer, Cassidy Henegar, Lloyd Curtis, Michael Aboud, Alan Winston and Romina Quercia and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Hepatology and AIDS.

In The Last Decade

Ricky Hsu

20 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ricky Hsu United States	9	161	92	85	64	50	20	255
Kevin R. Frost United States	7	187 1.2×	31 0.3×	117 1.4×	117 1.8×	62 1.2×	9	276
D. Nolan Australia	6	236 1.5×	171 1.9×	90 1.1×	172 2.7×	129 2.6×	11	370
J Lange Netherlands	9	193 1.2×	56 0.6×	147 1.7×	55 0.9×	16 0.3×	17	248
Suneeta Saghayam India	9	247 1.5×	123 1.3×	139 1.6×	77 1.2×	9 0.2×	12	319
Cassidy Henegar United States	10	162 1.0×	56 0.6×	55 0.6×	63 1.0×	6 0.1×	28	269
Maurizio D’Abbraccio Italy	7	145 0.9×	118 1.3×	63 0.7×	48 0.8×	23 0.5×	13	260
Helen Pearce United Kingdom	4	390 2.4×	387 4.2×	223 2.6×	75 1.2×	22 0.4×	6	569
Guenther Schmutz Germany	10	244 1.5×	116 1.3×	107 1.3×	233 3.6×	202 4.0×	19	444
Matthijs van Luin Netherlands	10	136 0.8×	21 0.2×	57 0.7×	67 1.0×	24 0.5×	27	260
Juan Tiraboschi Spain	13	312 1.9×	108 1.2×	244 2.9×	81 1.3×	13 0.3×	51	382

Countries citing papers authored by Ricky Hsu

Since Specialization

Citations

This map shows the geographic impact of Ricky Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricky Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricky Hsu more than expected).

Fields of papers citing papers by Ricky Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricky Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricky Hsu. The network helps show where Ricky Hsu may publish in the future.

Co-authorship network of co-authors of Ricky Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Ricky Hsu. A scholar is included among the top collaborators of Ricky Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricky Hsu. Ricky Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dieterich, Douglas T., Laurence Brunet, Ricky Hsu, et al.. (2024). WED-405 Tenofovir disoproxil fumarate and tenofovir alafenamide interruption in hepatitis B and human immunodeficiency virus co-infected individuals in the United States: monitoring practices and incidence of hepatitis B reactivation or hepatitis flare. Journal of Hepatology. 80. S799–S800. 1 indexed citations

Mounzer, Karam, Laurence Brunet, Ricky Hsu, et al.. (2021). Changes in Body Mass Index Associated with Antiretroviral Regimen Switch Among Treatment-Experienced, Virologically Suppressed People Living with HIV in the United States. AIDS Research and Human Retroviruses. 37(11). 852–861. 11 indexed citations

Brunet, Laurence, et al.. (2020). Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA. HIV Medicine. 21(5). 299–308. 4 indexed citations

Hsu, Ricky, Laurence Brunet, Jennifer S Fusco, et al.. (2020). Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score. HIV Medicine. 22(5). 325–333. 11 indexed citations

Wohlfeiler, Michael, Karam Mounzer, Laurence Brunet, et al.. (2020). Antiretroviral therapy and liver disorders in the OPERA^® cohort. Therapeutic Advances in Drug Safety. 11. 585518905–585518905. 1 indexed citations

Hsu, Ricky, Cassidy Henegar, Jennifer S Fusco, et al.. (2020). PIN89 REGIMEN DURABILITY AMONG HEAVILY TREATMENT-EXPERIENCED (HTE) COMPARED TO NON-HTE TREATMENT-EXPERIENCED HIV PATIENTS IN THE OPERA COHORT. Value in Health. 23. S183–S184. 1 indexed citations

Hsu, Ricky, Laurence Brunet, Jennifer S Fusco, et al.. (2020). Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. AIDS. 35(1). 81–90. 13 indexed citations

Mounzer, Karam, Laurence Brunet, Ricky Hsu, et al.. (2019). 978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV. Open Forum Infectious Diseases. 6(Supplement_2). S36–S37. 9 indexed citations

Hsu, Ricky, Laurence Brunet, Jennifer S Fusco, et al.. (2019). 341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States. Open Forum Infectious Diseases. 6(Supplement_2). S181–S182. 5 indexed citations

10.

Mounzer, Karam, Ricky Hsu, Jennifer S Fusco, et al.. (2019). HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study. AIDS Research and Therapy. 16(1). 1–1. 38 indexed citations

11.

Brunet, Laurence, Christina Wyatt, Ricky Hsu, et al.. (2019). Assessing Bias Introduced in Estimated Glomerular Filtration Rate by the Inhibition of Creatinine Tubular Secretion from Common Antiretrovirals. Antiviral Therapy. 25(5). 287–292. 6 indexed citations

12.

Hsu, Ricky, Jennifer S Fusco, Cassidy Henegar, et al.. (2018). Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database. Therapeutic Advances in Drug Safety. 9(12). 675–686. 7 indexed citations

13.

Lackey, Philip, Anthony Mills, Félix Carpio, et al.. (2016). Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice. Clinical Drug Investigation. 37(1). 51–60. 4 indexed citations

14.

Hsu, Ricky. (2016). Two Reported Cases of Only Primary Integrase Inhibitor Drug-Class Resistance Transmission including the First Reported Case of Primary Elvitegravir Resistance Transmission. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

15.

Winston, Alan, Naomi Givens, Vani Vannappagari, et al.. (2016). Psychiatric Symptoms in Patients Receiving Dolutegravir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(4). 423–431. 75 indexed citations

16.

Ando, Dale, Gary Blick, Jay Lalezari, et al.. (2015). 25. A Dose Escalation Study of Cyclophophamide (CTX) to Enhance SB-728-T Engraftment. Molecular Therapy. 23. S11–S11. 1 indexed citations

17.

Fierer, Daniel S., Douglas T. Dieterich, M. Isabel Fiel, et al.. (2012). Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection. Clinical Infectious Diseases. 56(7). 1038–1043. 46 indexed citations

18.

Hsu, Ricky, et al.. (2008). Effect of tenofovir subtraction on HIV plasma viraemia, CD4⁺ T-cell count and resistance in a patient with baseline K65R and M184V mutations. Antiviral Therapy. 13(5). 735–737. 1 indexed citations

19.

Elion, Richard, Calvin Cohen, Edwin DeJesus, et al.. (2006). Once-Daily Abacavir/Lamivudine/Zidovudine plus Tenofovir for the Treatment of HIV-1 Infection in Antiretroviral-NaïveSubjects: A 48-Week Pilot Study. HIV Clinical Trials. 7(6). 324–333. 12 indexed citations

20.

Hsu, Ricky, et al.. (1965). Influence of Vasopressors on Survival After Traumatic, Intestinal Ischemia and Endotoxin Shock in Rats.. Experimental Biology and Medicine. 119(2). 389–393. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact